Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| RXRX | Borgeson Blake | Director | 10/06/2026 | Verkauf | 4.84 | 50,000 | 242,000 | Form 4 |
| RXRX | Hershberg Robert | Director | 10/06/2026 | Verkauf | 5.00 | 25,000 | 125,000 | Form 4 |
| RXRX | Hershberg Robert | Director | 10/06/2026 | Optionsausübung | 2.22 | 25,000 | 55,500 | Form 4 |
| RXRX | Dar Zavain | Director | 10/01/2026 | Zuteilung | — | 4,607 | — | Form 4 |
| RXRX | Li Dean Y | Director | 10/01/2026 | Zuteilung | — | 3,378 | — | Form 4 |
| RXRX | Taylor Ben R | Chief Financial Officer | 09/15/2026 | Steuer-Abgabe | 3.41 | 5,396 | 18,400 | Form 4 |
| RXRX | Khan Najat | CEO and President | 09/08/2026 | Verkauf | 3.52 | 22,408 | 78,822 | Form 4 |
| RXRX | Borgeson Blake | Director | 09/01/2026 | Verkauf | 3.34 | 30,000 | 100,200 | Form 4 |
| RXRX | Khan Najat | CEO and President | 08/17/2026 | Steuer-Abgabe | 3.16 | 80,498 | 254,374 | Form 4 |
| RXRX | Hallett David | Chief Scientific Officer | 08/17/2026 | Steuer-Abgabe | 3.16 | 26,657 | 84,236 | Form 4 |
| RXRX | Taylor Ben R | Chief Financial Officer | 08/17/2026 | Steuer-Abgabe | 3.16 | 25,018 | 79,057 | Form 4 |
| RXRX | Borgeson Blake | Director | 08/04/2026 | Verkauf | 3.25 | 30,000 | 97,500 | Form 4 |
| RXRX | Borgeson Blake | Director | 07/07/2026 | Verkauf | 3.96 | 40,000 | 158,500 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).